Industry leaders from across the country will come to Washington DC and participate in two separate legislative fly-ins with the mission of educating members of Congress on the value of life science innovation.
Your voice is essential in humanizing the industry and aiding policy-makers in understanding the challenges facing life science organizations that are – or may in the future – threaten a company’s existence or negatively impact the industry’s ability to innovate and develop medical products, technologies, and treatments.
Join Oregon Bio for a unique advocacy experience and meet with the Michigan delegation to talk about topics that matter to you. Space is limited.
Key MedTech Legislative Priorities include:
– R&D Amorization
– Regulation of Lab Developed Tests (VALID Act)
– Coverage & Reimbursement for Emerging Technologies (TCET)
If you’re more interested in Biopharma related priorities, learn more about the BIO Legislative Fly-In on March 28/29.
